Literature DB >> 32428423

A non-human primate model of stroke reproducing endovascular thrombectomy and allowing long-term imaging and neurological read-outs.

Justine Debatisse1,2, Océane Wateau3,4, Tae-Hee Cho1,5,6, Nicolas Costes7, Inés Mérida7, Christelle Léon1, Jean-Baptiste Langlois7, Fabrice Taborik3, Michaël Verset3, Karine Portier1, Mohamed Aggour1, Thomas Troalen2, Marjorie Villien7, Nikolaos Makris5, Christian Tourvieille7, Didier Le Bars6,7, Sophie Lancelot6,7, Joachim Confais3, Adrien Oudotte6, Norbert Nighoghossian1,6, Michel Ovize1,6, Denis Vivien4,8, Hugues Contamin3, Véronique Agin4, Emmanuelle Canet-Soulas1, Omer Faruk Eker5,6.   

Abstract

Stroke is a devastating disease. Endovascular mechanical thrombectomy is dramatically changing the management of acute ischemic stroke, raising new challenges regarding brain outcome and opening up new avenues for brain protection. In this context, relevant experiment models are required for testing new therapies and addressing important questions about infarct progression despite successful recanalization, reversibility of ischemic lesions, blood-brain barrier disruption and reperfusion damage. Here, we developed a minimally invasive non-human primate model of cerebral ischemia (Macaca fascicularis) based on an endovascular transient occlusion and recanalization of the middle cerebral artery (MCA). We evaluated per-occlusion and post-recanalization impairment on PET-MRI, in addition to acute and chronic neuro-functional assessment. Voxel-based analyses between per-occlusion PET-MRI and day-7 MRI showed two different patterns of lesion evolution: "symptomatic salvaged tissue" (SST) and "asymptomatic infarcted tissue" (AIT). Extended SST was present in all cases. AIT, remote from the area at risk, represented 45% of the final lesion. This model also expresses both worsening of fine motor skills and dysexecutive behavior over the chronic post-stroke period, a result in agreement with cortical-subcortical lesions. We thus fully characterized an original translational model of ischemia-reperfusion damage after stroke, with consistent ischemia time, and thrombus retrieval for effective recanalization.

Entities:  

Keywords:  Endovascular non-human primate stroke model; PET-MRI imaging; ischemia–reperfusion; neurofunctional tests; thrombectomy

Year:  2020        PMID: 32428423      PMCID: PMC7983495          DOI: 10.1177/0271678X20921310

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  52 in total

1.  Simultaneous PET/MRI in stroke: a case series.

Authors:  Peter Werner; Dorothee Saur; Vilia Zeisig; Barbara Ettrich; Marianne Patt; Bernhard Sattler; Thies Jochimsen; Donald Lobsien; Philipp M Meyer; Florian Then Bergh; Antje Dreyer; Johannes Boltze; Joseph Classen; Dominik Fritzsch; Karl-Titus Hoffmann; Osama Sabri; Henryk Barthel
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-15       Impact factor: 6.200

Review 2.  A review of lateralization of spatial functioning in nonhuman primates.

Authors:  Anna Oleksiak; Albert Postma; Ineke J M van der Ham; P Christiaan Klink; Richard J A van Wezel
Journal:  Brain Res Rev       Date:  2010-11-06

3.  Experimental thromboembolic stroke in cynomolgus monkey.

Authors:  G Kito; A Nishimura; T Susumu; R Nagata; Y Kuge; C Yokota; K Minematsu
Journal:  J Neurosci Methods       Date:  2001-01-30       Impact factor: 2.390

Review 4.  Reconsidering Neuroprotection in the Reperfusion Era.

Authors:  Sean I Savitz; Jean-Claude Baron; Midori A Yenari; Nerses Sanossian; Marc Fisher
Journal:  Stroke       Date:  2017-11-16       Impact factor: 7.914

5.  Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke.

Authors:  Yingqian Zhang; Feng Fan; Guojun Zeng; Linlin Zhou; Yinbing Zhang; Jie Zhang; He Jiao; Ting Zhang; Dan Su; Cheng Yang; Xin Wang; Kai Xiao; Hongxia Li; Zhihui Zhong
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 6.  Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke.

Authors:  Giora Z Feuerstein; Margaret M Zaleska; Michael Krams; Xinkang Wang; Mark Day; Julia L Rutkowski; Seth P Finklestein; Menelas N Pangalos; Michael Poole; Gary L Stiles; Robert R Ruffolo; Frank L Walsh
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-20       Impact factor: 6.200

7.  Stroke Longitudinal Volumetric Measures Correlate with the Behavioral Score in Non-Human Primates.

Authors:  Gabriel Ramirez-Garcia; Kathleen A Harrison; Juan Fernandez-Ruiz; Joseph Y Nashed; Douglas J Cook
Journal:  Neuroscience       Date:  2018-11-24       Impact factor: 3.590

8.  Editorial: the ischemic penumbra: still the target for stroke therapies?

Authors:  Argye E Hillis; Jean-Claude Baron
Journal:  Front Neurol       Date:  2015-04-22       Impact factor: 4.003

9.  Six-month functional recovery of stroke patients: a multi-time-point study.

Authors:  Kyoung Bo Lee; Seong Hoon Lim; Kyung Hoon Kim; Ki Jeon Kim; Yang Rae Kim; Woo Nam Chang; Jun Woo Yeom; Young Dong Kim; Byong Yong Hwang
Journal:  Int J Rehabil Res       Date:  2015-06       Impact factor: 1.479

10.  Quantifying Infarct Growth and Secondary Injury Volumes: Comparing Multimodal Image Registration Measures.

Authors:  George W J Harston; Davide Carone; Fintan Sheerin; Mark Jenkinson; James Kennedy
Journal:  Stroke       Date:  2018-06-12       Impact factor: 7.914

View more
  4 in total

Review 1.  A clinically relevant model of focal embolic cerebral ischemia by thrombus and thrombolysis in rhesus monkeys.

Authors:  Di Wu; Jian Chen; Longfei Wu; Hangil Lee; Jingfei Shi; Mo Zhang; Yanhui Ma; Xiaoduo He; Zixin Zhu; Feng Yan; Chuanjie Wu; Yunxia Duan; Yongjuan Fu; Sijie Li; Xinglong Zhi; Xuxiang Zhang; Shengli Li; Yuchuan Ding; Xunming Ji
Journal:  Nat Protoc       Date:  2022-06-27       Impact factor: 17.021

2.  Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model.

Authors:  Vanessa Di Cataldo; Justine Debatisse; Joao Piraquive; Alain Géloën; Clément Grandin; Michaël Verset; Fabrice Taborik; Emmanuel Labaronne; Emmanuelle Loizon; Antoine Millon; Pauline Mury; Vincent Pialoux; André Serusclat; Franck Lamberton; Danielle Ibarrola; Franck Lavenne; Didier Le Bars; Thomas Troalen; Joachim Confais; Claire Crola Da Silva; Laura Mechtouff; Hugues Contamin; Zahi A Fayad; Emmanuelle Canet-Soulas
Journal:  Brain Commun       Date:  2021-04-01

Review 3.  Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke.

Authors:  Kelsy L Nilles; Erica I Williams; Robert D Betterton; Thomas P Davis; Patrick T Ronaldson
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

Review 4.  Preclinical animal studies in ischemic stroke: Challenges and some solutions.

Authors:  Sunil K Narayan; Simy Grace Cherian; Prakash Babu Phaniti; Saravana Babu Chidambaram; A Hannah Rachel Vasanthi; Murugesan Arumugam
Journal:  Animal Model Exp Med       Date:  2021-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.